The global antibacterial drugs market is growing due to rising infection rates, antibiotic resistance, and advancements in drug development. Demand is driven by broad-spectrum antibiotics, aging populations, and improved healthcare access. While North America leads, Asia-Pacific is emerging rapidly with increased healthcare investment and infection control efforts. https://www.uniprismmarketresearch.com/verticals/healthcare/antibacterial-drugs